HIMS vs. SMMT
HIMS (Hims & Hers Health, Inc.) and SMMT (Summit Therapeutics Inc.) are both stocks. HIMS operates in Household & Personal Products (Consumer Defensive), while SMMT operates in Biotechnology (Healthcare). Over the past 5 years, HIMS returned 15.10%/yr vs 13.84%/yr for SMMT. At a 0.21 correlation, their price movements are largely independent.
Performance
HIMS vs. SMMT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HIMS achieves a -16.32% return, which is significantly higher than SMMT's -19.33% return.
HIMS
- 1D
- 3.74%
- 1M
- -3.89%
- YTD
- -16.32%
- 6M
- -30.55%
- 1Y
- -51.77%
- 3Y*
- 44.53%
- 5Y*
- 15.10%
- 10Y*
- —
SMMT
- 1D
- -4.47%
- 1M
- -21.96%
- YTD
- -19.33%
- 6M
- -24.24%
- 1Y
- -31.47%
- 3Y*
- 100.52%
- 5Y*
- 13.84%
- 10Y*
- 4.15%
HIMS vs. SMMT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
HIMS Hims & Hers Health, Inc. | -16.32% | 34.28% | 171.69% | 38.85% | -2.14% | -55.14% | 47.47% | 1.23% |
SMMT Summit Therapeutics Inc. | -19.33% | -1.99% | 583.72% | -38.59% | 57.99% | -42.77% | 193.75% | 11.14% |
Correlation
The correlation between HIMS and SMMT is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | 0.21 |
Fundamentals
HIMS:
$6.20B
SMMT:
$10.94B
HIMS:
-$0.05
SMMT:
-$1.60
HIMS:
13.91
SMMT:
20.04
HIMS:
$2.37B
SMMT:
$0.00
HIMS:
$1.70B
SMMT:
-$83.36K
HIMS:
$16.04M
SMMT:
-$738.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HIMS vs. SMMT — Risk / Return Rank
HIMS
SMMT
HIMS vs. SMMT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HIMS | SMMT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.12 | ||
| Sortino ratioReturn per unit of downside risk | -0.27 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 0.98 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | -0.67 | -0.60 | -0.07 |
| Martin ratioReturn relative to average drawdown | -1.09 | -0.92 | -0.17 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HIMS | SMMT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.54 | -0.42 | -0.12 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.18 | 0.08 | +0.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.03 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | 0.02 | +0.19 |
Drawdowns
HIMS vs. SMMT - Drawdown Comparison
The maximum HIMS drawdown since its inception was -87.29%, smaller than the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for HIMS and SMMT.
Loading charts...
Drawdown Indicators
| HIMS | SMMT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.29% | -95.75% | +8.46% |
Max Drawdown (1Y)Largest decline over 1 year | -78.06% | -52.76% | -25.30% |
Max Drawdown (3Y)Largest decline over 3 years | -78.88% | -62.26% | -16.62% |
Max Drawdown (5Y)Largest decline over 5 years | -78.88% | -91.78% | +12.90% |
Max Drawdown (10Y)Largest decline over 10 years | — | -95.75% | — |
Current DrawdownCurrent decline from peak | -60.47% | -61.55% | +1.08% |
Average DrawdownAverage peak-to-trough decline | -43.22% | -57.64% | +14.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.51% | 34.32% | +13.19% |
Volatility
HIMS vs. SMMT - Volatility Comparison
Hims & Hers Health, Inc. (HIMS) has a higher volatility of 26.28% compared to Summit Therapeutics Inc. (SMMT) at 22.47%. This indicates that HIMS's price experiences larger fluctuations and is considered to be riskier than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HIMS | SMMT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.28% | 22.47% | +3.81% |
Volatility (6M)Calculated over the trailing 6-month period | 66.46% | 56.53% | +9.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 96.13% | 75.95% | +20.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.39% | 185.12% | -101.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.19% | 144.63% | -67.44% |
Dividends
HIMS vs. SMMT - Dividend Comparison
Neither HIMS nor SMMT has paid dividends to shareholders.
Financials
HIMS vs. SMMT - Financials Comparison
This section allows you to compare key financial metrics between Hims & Hers Health, Inc. and Summit Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
HIMS and SMMT have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HIMS has higher volatility (26.28%) compared to SMMT (22.47%). In terms of maximum drawdown, HIMS dropped -87.29% vs SMMT's -95.75%.
SMMT currently has the higher Sharpe Ratio (-0.42 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HIMS and SMMT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer